Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeutics in 2022.

A government program allowing taxpayers to file federal tax returns for free has been terminated, but there are still many no-cost options available, especially if you have a simple tax return.